X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (177) 177
male (136) 136
index medicus (133) 133
female (129) 129
middle aged (99) 99
aged (93) 93
hematology (80) 80
life sciences (80) 80
adult (70) 70
treatment outcome (61) 61
surgery (54) 54
aged, 80 and over (51) 51
peripheral vascular disease (46) 46
oncology (43) 43
rituximab (43) 43
cancer (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
prognosis (32) 32
retrospective studies (32) 32
time factors (30) 30
chemotherapy (28) 28
animals (26) 26
risk factors (26) 26
prospective studies (25) 25
lymphoma (24) 24
lymphomas (23) 23
cyclophosphamide (22) 22
hemic and lymphatic diseases (22) 22
[sdv]life sciences [q-bio] (21) 21
leukemia, lymphocytic, chronic, b-cell - drug therapy (21) 21
survival (21) 21
follow-up studies (20) 20
france (20) 20
adolescent (19) 19
analysis (19) 19
[ sdv ] life sciences [q-bio] (18) 18
care and treatment (18) 18
human health and pathology (18) 18
trial (18) 18
[sdv.can]life sciences [q-bio]/cancer (17) 17
abridged index medicus (17) 17
dogs (17) 17
management (17) 17
medicine, general & internal (17) 17
non-hodgkins-lymphoma (17) 17
therapy (17) 17
transplantation (17) 17
cyclophosphamide - administration & dosage (16) 16
disease (16) 16
patients (16) 16
survival analysis (16) 16
diagnosis (15) 15
risk (15) 15
veterinary sciences (15) 15
[ sdv.can ] life sciences [q-bio]/cancer (14) 14
blood vessel prosthesis (14) 14
disease-free survival (14) 14
doxorubicin (14) 14
lymphoma, follicular - drug therapy (14) 14
lymphoma, large b-cell, diffuse - drug therapy (14) 14
prednisone (14) 14
young adult (14) 14
antineoplastic agents - therapeutic use (13) 13
cyclophosphamide - therapeutic use (13) 13
flow cytometry (13) 13
mortality (13) 13
outcomes (13) 13
survival rate (13) 13
vincristine (13) 13
aneurysms (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
aortic aneurysm, abdominal - surgery (12) 12
atherosclerosis (12) 12
hematopoietic stem cell transplantation (12) 12
immune system diseases (12) 12
research (12) 12
doxorubicin - administration & dosage (11) 11
health aspects (11) 11
medicine (11) 11
multivariate analysis (11) 11
stents (11) 11
studies (11) 11
transplantation, autologous (11) 11
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (10) 10
antibodies, monoclonal, murine-derived - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
blood vessel prosthesis implantation - adverse effects (10) 10
immunology (10) 10
kaplan-meier estimate (10) 10
leukemia, lymphocytic, chronic, b-cell - mortality (10) 10
medicine & public health (10) 10
remission induction (10) 10
tomography, x-ray computed (10) 10
vincristine - administration & dosage (10) 10
antibodies, monoclonal, murine-derived (9) 9
b-cell lymphoma (9) 9
blood vessel prosthesis implantation - instrumentation (9) 9
chronic lymphocytic leukemia (9) 9
chronic lymphocytic-leukemia (9) 9
clinical trials (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Vascular & Endovascular Surgery, ISSN 1078-5884, 2015, Volume 50, Issue 3, pp. 303 - 310
Journal Article
by Sweeting, M. J and Balm, R and Desgranges, P and Ulug, P and Powell, J. T and Koelemay, M. J. W and Idu, M. M and Kox, C and Legemate, D. A and Huisman, L. C and Willems, M. C. M and Reekers, J. A and van Delden, O. M and van Lienden, K. P and Hoornweg, L. L and Reimerink, J. J and van Beek, S. C and Vahl, A. C and Leijdekkers, V. J and Bosma, J and Montauban van Swijnegt, A. D and de Vries, C and van der Hulst, V. P. M and Peringa, J and Blomjous, J. G. A. M and Visser, M. J. T and van der Heijden, F. H. W. M and Wisselink, W and Hoksbergen, A. W. J and Blankensteijn, J. D and Visser, M. T. J and Coveliers, H. M. E and Nederhoed, J. H and van den Berg, F. G and van der Meijs, B. B and van den Oever, M. L. P and Lely, R. J and Meijerink, M. R and Voorwinde, A and Ultee, J. M and van Nieuwenhuizen, R. C and Dwars, B. J and Nagy, T. O. M and Tolenaar, P and Wiersema, A. M and Lawson, J. A and van Aken, P. J and Stigter, A. A and van den Broek, T. A. A and Vos, G. A and Mulder, W and Strating, R. P and Nio, D and Akkersdijk, G. J. M and van der Elst, A and van Exter, P and Becquemin, J.-P and Allaire, E and Cochennec, F and Marzelle, J and Louis, N and Schneider, J and Majewski, M and Castier, Y and Leseche, G and Francis, F and Steinmetz, E and Berne, J.-P and Favier, C and Haulon, S and Koussa, M and Azzaoui, R and Piervito, D and Alimi, Y and Boufi, M and Hartung, O and Cerquetta, P and Amabile, P and Piquet, P and Penard, J and Demasi, M and Alric, P and Canaud, L and Berthet, J.-P and Julia, P and Fabiani, J.-N and Alsac, J. M and Gouny, P and Baa, A and Braesco, J and Favre, J.-P and Albertini, J.-N and Martinez, R and Hassen-Khodja, R and Batt, M and Jean, E and Sosa, M and Declemy, S and Destrieux-Garnier, L and Lermusiaux, P and ... and Ruptured Aneurysm Trialists
British journal of surgery, ISSN 0007-1323, 2015, Volume 102, Issue 10, pp. 1229 - 1239
The benefits of endovascular repair of ruptured abdominal aortic aneurysm remain controversial, without any strong evidence about advantages in specific... 
SURGERY | SURVIVAL | IMPROVE | MANAGEMENT | OUTCOMES | COMPARTMENT SYNDROME | Endovascular Procedures - methods | Vascular Surgical Procedures - methods | Aortic Aneurysm, Abdominal - surgery | Humans | Treatment Outcome | Aortic Rupture - surgery | Randomized Controlled Trials as Topic | Abdominal aneurysm | Mortality | Analysis | Original
Journal Article
by Sweeting, M. J and Ulug, P and Roy, J and Hultgren, R and Indrakusuma, R and Balm, R and Thompson, M. M and Hinchliffe, R. J and Thompson, S. G and Powell, J. T and Balm, R and Koelemay, M. J. W and Idu, M. M and Kox, C and Legemate, D. A and Huisman, L. C and Willems, M. C. M and Reekers, J. A and van Delden, O. M and van Lienden, K. P and Hoornweg, L. L and Reimerink, J. J and van Beek, S. C and Vahl, A. C and Leijdekkers, V. J and Bosma, J and Montauban van Swijndregt, A. D and de Vries, C and van der Hulst, V. P. M and Peringa, J and Blomjous, J. G. A. M and Visser, M. J.T and van der Heijden, F. H.W. M and Wisselink, W and Hoksbergen, A.W. J and Blankensteijn, J. D and Visser, M. T. J and Coveliers, H. M. E and Nederhoed, J. H and van den Berg, F. G and van der Meijs, B. B and van den Oever, M. L. P and Lely, R. J and Meijerink, M. R and Westra, I and Voorwinde, A and Ultee, J. M and van Nieuwenhuizen, R. C and Dwars, B. J and Nagy, T. O. M and Tolenaar, P and Wiersema, A. M and Lawson, J. A and van Aken, P. J and Stigter, A. A and van den Broek, T. A. A and Vos, G. A and Mulder, W and Strating, R. P and Nio, D and Akkersdijk, G. J. M and van der Elst, A and van Exter, P and Desgranges, P and Becquemin, J.‐P and Allaire, E and Cochennec, F and Marzelle, J and Louis, N and Schneider, J and Majewski, M and Castier, Y and Leseche, G and Francis, F and Steinmetz, E and Berne, J.‐P and Favier, C and Haulon, S and Koussa, M and Azzaoui, R and Piervito, D and Alimi, Y and Boufi, M and Hartung, O and Cerquetta, P and Amabile, P and Piquet, P and Penard, J and Demasi, M and Alric, P and Cannaud, L and Berthet, J.‐P and Julia, P and Fabiani, J.‐N and Alsac, J. M and Gouny, P and Badra, A and Braesco, J and Favre, J.‐P and Albertini, J.‐N and ... and IMPROVE Collaborator and Ruptured Aneurysm Collaborators and AJAX Collaborator and ECAR Collaborator and STAR Collaborator and STAR Cohort investigators and ECAR Trial investigators and IMPROVE Trial investigators: management committee and Ruptured Aneurysm Collaborators: AJAX Trial investigators
British Journal of Surgery, ISSN 0007-1323, 08/2018, Volume 105, Issue 9, pp. 1135 - 1144
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | COMBINATION | FLUDARABINE | STUDY-GROUP GLSG | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 12, pp. 1160 - 1170
Summary Background Little is known about the longitudinal course of health-related quality of life (HRQoL) in patients with Hodgkin's lymphoma during their... 
Hematology, Oncology and Palliative Medicine | INSTRUMENT | LONG-TERM SURVIVORS | GENERAL-POPULATION | ONCOLOGY | FATIGUE | QLQ-C30 | DISEASE SURVIVORS | CANCER | Hodgkin Disease - psychology | Follow-Up Studies | Humans | Middle Aged | Adolescent | Hodgkin Disease - drug therapy | Quality of Life | Adult | Female | Male | Aged
Journal Article
Leukemia, ISSN 0887-6924, 10/2008, Volume 22, Issue 10, pp. 1917 - 1924
Gene expression profiles have been associated with clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with... 
PROGNOSTIC IMPACT | DLBCL | R-CHOP | CLASSIFICATION | GERMINAL CENTER | prognosis | LPP | CHEMOTHERAPY | diffuse B-cell lymphoma | ONCOLOGY | PROTEIN EXPRESSION | TISSUE MICROARRAY | HEMATOLOGY | TRANSCRIPTION FACTOR | rituximab | gene expression | Multivariate Analysis | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cytoskeletal Proteins - genetics | Humans | Middle Aged | Male | rab GTP-Binding Proteins - genetics | Gene Expression Profiling | Metalloproteins - genetics | Aged, 80 and over | Lymphoma, Large B-Cell, Diffuse - immunology | Vincristine - administration & dosage | Female | Proto-Oncogene Proteins | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Lymphoma, Large B-Cell, Diffuse - drug therapy | LIM Domain Proteins | Cytidine Deaminase - genetics | Repressor Proteins - genetics | Rituximab | DNA-Binding Proteins - genetics | Forkhead Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Lymphoma, Large B-Cell, Diffuse - mortality | APOBEC-3G Deaminase | Adaptor Proteins, Signal Transducing | Antibodies, Monoclonal - administration & dosage | Aged | Lymphoma, Large B-Cell, Diffuse - genetics | Genetic aspects | Research | Non-Hodgkin's lymphomas | Gene expression | Drug therapy | Index Medicus | Cytoskeletal Proteins | Lymphoma, Large B-Cell, Diffuse | Cytidine Deaminase | Repressor Proteins | Doxorubicin | Life Sciences | DNA-Binding Proteins | Biochemistry, Molecular Biology | Antineoplastic Combined Chemotherapy Protocols | Prednisone | Antibodies, Monoclonal | Metalloproteins | Vincristine | Cyclophosphamide | rab GTP-Binding Proteins | Forkhead Transcription Factors | Antibodies | genetics | administration & dosage | Monoclonal | immunology | drug therapy | mortality
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 7/2007, Volume 18, Issue 7, pp. 1209 - 1215
Journal Article